Ciclosporin 10 years on: Indications and efficacy

Veterinary Record

Volumn 174, Issue SUPPL.2, 2014, Pages 13-21

  Forsythe, Peter ^a   Paterson, Sue ^b  

^a Dermatology Referral Service   (United Kingdom)

^b RUTLAND HOUSE REFERRALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ATOPIC DERMATITIS; DOG; DOG DISEASE; REVIEW; TREATMENT OUTCOME; VETERINARY MEDICINE;

ANIMALS; CYCLOSPORINE; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME; VETERINARY MEDICINE;

EID: 84897146331     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.102484     Document Type: Review

References (95)

1. AFFOLTER, V. K. & MOORE, P. F. (2000) Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. American Journal of Dermatopathology 22, 40-48
2. AMATORI, F. M., GIUSIANI, V. M. M., SOLDANI, G., CORAZZA, M. & GIORGI, M. (2004) Effect of grapefruit juice on the pharmacokinetics of cyclosporine in dogs. Veterinary Record 154, 180-181
3. ANGUS, J. C., LICHTENSTEIGER, C., CAMPBELL, K. L. & SCHAEFFER, D. J. (2002) Breed variations in histopathologic features of chronic severe otitis externa in dogs: 80 cases (1995-2001). Journal of the American Veterinary Medical Association 221, 1000-1006
4. BARDAGI, M., LLORET, A., FONDATI, A. & FERRER, L. (2007) Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis. Journal of Small Animal Practice 48, 229-232
5. BAUER, S., STORMER, E., JOHNE, A., KRUGER, H., BUDDE, K., NEUMAYER, H. H., ROOTS, I. & MAI, I. (2003) Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. British Journal of Clinical Pharmacology 55, 203-211
6. BAUMER, W. & KIETZMANN, M. (2007) Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. Veterinary Dermatology 18, 107-114
7. BENSIGNOR, E. & GUAGUÈRE, E. (2004) Utilisation de la ciclosporine pour le traitement des formes rebelles de dermatite atopique canine. Pratique Medicale et Chirurgicale de L'Animal de Compagnie 39, 15-19
8. BLACKWOOD, S. E., BARRIE, K. P., PLUMMER, C. E., TAYLOR, D., NUNNERY, C. M., SELTZER, J. D., BEN-SHLOMO, G. & BROOKS, D. E. (2011) Uveodermatologic syndrome in a rat terrier. Journal of the American Animal Hospital Association 47, e56-63
9. BRANDT, C., PAVLOVIC, V., RADBRUCH, A., WORM, M. & BAUMGRASS, R. (2009) Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy 64, 1588-1596
10. BRAZIS, P., BARANDICA, L., GARCIA, F., CLOUGH, G. F., CHURCH, M. K. & PUIGDEMONT, A. (2006) Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. Veterinary Dermatology 17, 169-174
11. BREATHNACH, R. M., BAKER, K. P., QUINN, P. J., MCGEADY, T. A., AHERNE, C. M. & JONES, B. R. (2005) Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis. Veterinary Dermatology 16, 364-372
12. BRUNER, S. R. (2006) Updates in therapeutics for veterinary dermatology. Veterinary Clinics of North America: Small Animal Practice 36, 39-58, vi
13. BUNIKOWSKI, R., GERHOLD, K., BRAUTIGAM, M., HAMELMANN, E., RENZ, H. & WAHN, U. (2001) Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. International Archive of Allergy and Immunology 125, 344-348
14. BURTON, G., BURROWS, A., WALKER, R., ROBSON, D., BASSETT, R., BRYDEN, S. & HILL, A. (2004) Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs-combined results from two veterinary dermatology referral centres. Australian Veterinary Journal 82, 681-685
15. BUSSMANN, C., BIEBER, T. & NOVAK, N. (2009) Systemic therapeutic options for severe atopic dermatitis. Journal of the German Society of Dermatology 7, 205-219
16. CAMPANA, C., REGAZZI, M., BUGGIA, I. & MOLINARO, M. (1996) Clinically significant drug interactions with cyclosporin-an update. Clinical Pharmacokinetics 30, 141-179
17. CARLOTTI, D. N., BOULET, M., DUCRET, J., MACHICOTE, G., JASMIN, P., REME, C. A. & ALBOUY, M. (2009) The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Veterinary Dermatology 20, 405-411
18. CAROTHERS, M. A., KWOCHKA, K. W. & ROJKO, J. L. (1991) Cyclosporineresponsive granulomatous sebaceous adenitis in a dog. Journal of the American Veterinary Medical Association 198, 1645-1648
19. CIRILLO, R., TRIGGIANI, M., SIRI, L., CICCARELLI, A., PETTIT, G. R., CONDORELLI, M. & MARONE, G. (1990) Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Journal of Immunology 144, 3891-3897
20. COCKERILL, G. W., BERT, A. G., RYAN, G. R., GAMBLE, J. R., VADAS, M. A. & COCKERILL, P. N. (1995) Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood 86, 2689-2698
21. DAHLINGER, J., GREGORY, C. & BEA, J. (1998) Effect of ketoconazole on cyclosporine dose in healthy dogs. Veterinary Surgery 27, 64-68
22. DAIGLE, J. C., HOSGOOD, G., FOIL, C. S. & HUNTER, R. P. (2001) Effect of cimetidine on pharmacokinetics of orally administered cyclosporine in healthy dogs. American Journal of Veterinary Research 62, 1046-1050
23. DANDRIEUX, J. R., TIMM, K., ROOSJE, P. J., WELLE, M., HOWARD, J., BRUHSCHWEIN, A. & FRANCEY, T. (2011) Unusual systemic signs in a dog with sterile neutrophilic-macrophagic lymphadenitis and nodular panniculitis. Journal of the American Animal Hospital Association 47, 117-121
24. DIP, R., CARMICHAEL, J., LETELLIER, I., STREHLAU, G., ROBERTS, E., BENSIGNOR, E. & ROSENKRANTZ, W. (2013) Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. BMC Veterinary Research doi: 10.1186/1746-6148-9-173
25. DOUST, R., GRIFFITHS, L. G. & SULLIVAN, M. (2003) Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs. Veterinary Record 152, 225-229
26. FAHR, A., HIESTAND, P. & RYFFEL, B. (1990) Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments. Transplantation Proceedings 22, 1116-1124
27. FONT, A., BARDAGI, M., MASCORT, J. & FONDEVILA, D. (2006) Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie. Veterinary Dermatology 17, 440-442
28. FONTAINE, J. & OLIVRY, T. (2001) Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Veterinary Record 148, 662-663
29. FRIC, J., ZELANTE, T., WONG, A. Y., MERTES, A., YU, H. B. & RICCIARDICASTAGNOLI, P. (2012) NFAT control of innate immunity. Blood 120, 1380-1389
30. FUKUNAGA, K. & ORITO, K. (2012) Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs. Journal of Veterinary Pharmacology and Therapeutics 35, 446-451
31. GOLDMAN, C., ROSSER, Jr, E., PETERSEN, A. & HAUPTMAN, J. (2010) Investigation on the effects of ciclosporin (Atopica) on intradermal test reactivity and allergen-specific immunoglobulin (IgE) serology in atopic dogs. Veterinary Dermatology 21, 393-399
32. GRAY, L. L., HILLIER, A., COLE, L. K. & RAJALA-SCHULTZ, P. J. (2013) The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs. Veterinary Dermatology 24, 118-125
33. GRIFFITHS, L. G., SULLIVAN, M. & BORLAND, W. W. (1999) Cyclosporine as the sole treatment for anal furunculosis: preliminary results. Journal of Small Animal Practice 40, 569-572
34. GUAGUÈRE, E. (2000) Efficacy of ciclosporin in the treatment of idiopathic sterile nodular panniculitis in two dogs. Veterinary Dermatology 11 (suppl 1), 22
35. GUAGUÈRE, E., STEFFAN, J. & OLIVRY, T. (2004) Cyclosporin A: a new drug in the field of canine dermatology. Veterinary Dermatology 15, 61-74
36. HALL, J. A., WAISGLASS, S. E., MATHEWS, K. A. & TAIT, J. L. (2003) Oral cyclosporin in the treatment of end-stage ear disease: a pilot study. Veterinary Dermatology 14, 212
37. HARDIE, R. J., GREGORY, S. P., TOMLIN, J., STURGEON, C., LIPSCOMB, V. & LADLOW, J. (2005) Cyclosporine treatment of anal furunculosis in 26 dogs. Journal of Small Animal Practice 46, 3-9
38. HARGIS, A. M., MYERS, S., GORTEL, K., DUCLOS, D. & RANDOLPHHABECKER, J. (2013) Proliferative, lymphocytic, infundibular mural folliculitis and dermatitis with prominent follicular apoptosis and parakeratotic casts in four Labrador retrievers: preliminary description and response to therapy. Veterinary Dermatology 24, 346-354, e376-347
39. HATFIELD, S. M. & ROEHM, N. W. (1992) Cyclosporine and FK506 inhibition of murine mast cell cytokine production. Journal of Pharmacology and Experimental Therapeutics 260, 680-688
40. HO, S., CLIPSTONE, N., TIMMERMANN, L., NORTHROP, J., GRAEF, I., FIORENTINO, D., NOURSE, J. & CRABTREE, G. R. (1996) The mechanism of action of cyclosporin A and FK506. Clinical Immunology and Immunopathology 80, S40-45
41. HOUSE, A. K., GUITIAN, J., GREGORY, S. P. & HARDIE, R. J. (2006) Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. Veterinary Surgery 35, 543-549
42. KATAYAMA, M., IGARASHI, H., TANI, K., NEZU, Y., HARADA, Y., YOGO, T., HARA, Y., AOKI, S. & TAGAWA, M. (2008) Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. Journal of Veterinary Medical Science 70, 85-88
43. KATAYAMA, M., KAWAKAMI, Y., KATAYAMA, R., SHIMAMURA, S., OKAMURA, Y. & UZUKA, Y. (2013) Preliminary study of effects of multiple oral dosing of clarithromycin on the pharmacokinetics of cyclosporine in dogs. Journal of Veterinary Medical Science Nov 5, epub
44. KENNEDY, L. J., O'NEILL, T., HOUSE, A., BARNES, A., KYOSTILA, K., INNES, J., FRETWELL, N., DAY, M. J., CATCHPOLE, B., LOHI, H. & OLLIER, W. E. (2008) Risk of anal furunculosis in German shepherd dogs is associated with the major histocompatibility complex. Tissue Antigens 71, 51-56
45. KEPPEL, K. E., CAMPBELL, K. L., ZUCKERMANN, F. A., GREELEY, E. A., SCHAEFFER, D. J. & HUSMANN, R. J. (2008) Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 123, 337-344
46. KIM, H. J., KANG, M. H., KIM, J. H., KIM, D. & PARK, H. M. (2011) Sterile panniculitis in dogs: new diagnostic findings and alternative treatments. Veterinary Dermatology 22, 352-359
47. KLEIN, A., DENEUCHE, A., FAYOLLE, P., HIDALGO, A., SCOTTI, S., ZYLBERSTEIN, L., DESBOIS, C., TESSIER, D., MOISSONNIER, P. & VIATEAU, V. (2006) Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis. Veterinary Surgery 35, 759-768
48. KOVALIK, M., TASZKUN, I., POMORSKI, Z., KOZAK, M., POMORSKA, D., SZCZEPANIK, M. & OTHERS (2011) Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells. Veterinary Record doi: 10.1136/vr.c7365
49. KU, Y. M., MIN, D. I. & FLANIGAN, M. (1998) Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter? Journal of Clinical Pharmacology 38, 959-965
50. LINEK, M., BOSS, C., HAEMMERLING, R., HEWICKER-TRAUTWEIN, M. & MECKLENBURG, L. (2005) Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis. Journal of the American Veterinary Medical Association 226, 59-64
51. LORTZ, J., FAVROT, C., MECKLENBURG, L., NETT, C., RUFENACHT, S., SEEWALD, W. & LINEK, M. (2010) A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment. Veterinary Dermatology 21, 593-601
52. MACIAN, F. (2005) NFAT proteins: key regulators of T-cell development and function. Nature Reviews Immunology 5, 472-484
53. MAEDA, H., TAKAHASHI, M., NAKASHIMA, K., FUJINO, Y., OHNO, K., TSUJIMOTO, H., TAKAHASHI, K., KANAMARU, A. & FUKAMACHI, T. (2008) Treatment of five dogs with pemphigus foliaceus with cyclosporine and prednisolone. Veterinary Dermatology 19, 51
54. MARSELLA, R. & OLIVRY, T. (2001) The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 81, 331-345
55. MATHEWS, K. A. & SUKHIANI, H. R. (1997) Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. Journal of the American Veterinary Medical Association 211, 1249-1253
56. MATSUDA, S. & KOYASU, S. (2000) Mechanisms of action of cyclosporine. Immunopharmacology 47, 119-125
57. MAULDIN, E. A., MORRIS, D. O., BROWN, D. C. & CASAL, M. L. (2010) Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment. Veterinary Dermatology 21, 373-382
58. MOUATT, J. G. (2002) Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog. Australian Veterinary Journal 80, 207-211
59. NOLI, C. & TOMA, S. (2006) Three cases of immune-mediated adnexal skin disease treated with cyclosporin. Veterinary Dermatology 17, 85-92
60. NUTTALL, T. J., MCEWAN, N. A., BENSIGNOR, E., CORNEGLIANI, L., LOWENSTEIN, C. & REME, C. A. (2012) Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Veterinary Dermatology 23, 4-10, e11-12
61. Nutta ll, T., Reece, D. & Roberts, E. (2014) Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis. Veterinary Record 174 (suppl 2), 3-11
62. O'NEILL, T., EDWARDS, G. A. & HOLLOWAY, S. (2004) Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis. Journal of Small Animal Practice 45, 238-243
63. OLIVEIRA, A. M., OBWOLO, M. J., VAN DEN BROEK, A. H. & THODAY, K. L. (2007) Focal metatarsal sinus tracts in a Weimaraner successfully managed with ciclosporin. Journal of Small Animal Practice 48, 161-164
64. OLIVRY, T. (2004) A systematic review and meta-analysis of the efficacy of cyclosporine for treatment of canine atopic dermatitis. 5th World Congress of Veterinary Dermatology. Proceedings of the Atopica Symposium. Vienna. pp 4-14
65. OLIVRY, T. & BIZIKOVA, P. (2013) A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Veterinary Dermatology 24, 97-117
66. OLIVRY, T., RIVIERRE, C., JACKSON, H. A., MURPHY, K. M., DAVIDSON, G. & SOUSA, C. A. (2002a) Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 13, 77-87
67. OLIVRY, T., RIVIERRE, C. & MURPHY, K. M. (2003a) Efficacy of cyclosporine for treatment induction of canine pemphigus foliaceus. Veterinary Record 152, 53-54
68. OLIVRY, T., RIVIERRE, C., MURPHY, K. M., JACKSON, H. A. & CHAVEZ, F. (2003b) Maintenance treatment of canine atopic dermatitis with cyclosporin: decreasing dosages or increasing intervals? Veterinary Dermatology 14, 220
69. OLIVRY, T., STEFFAN, J., FISCH, R. D., PRELAUD, P., GUAGUÈRE, E., FONTAINE, J. & CARLOTTI, D. N. (2002b) Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 221, 370-377
70. ORAN, A., MARSHALL, J. S., KONDO, S., PAGLIA, D. & MCKENZIE, R. C. (1997) Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation. British Journal of Dermatology 136, 519-526
71. PALMEIRO, B. S., MORRIS, D. O., GOLDSCHMIDT, M. H. & MAULDIN, E. A. (2007) Cutaneous reactive histiocytosis in dogs: a retrospective evaluation of 32 cases. Veterinary Dermatology 18, 332-340
72. PATRICELLI, A. J., HARDIE, R. J. & MCANULTY, J. E. (2002) Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. Journal of the American Veterinary Medical Association 220, 1009-1016
73. PUIGDEMONT, A., BRAZIS, P., ORDEIX, L., DALMAU, A., FUERTES, E., OLIVAR, A., PEREZ, C. & RAVERA, I. (2013) Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs. Veterinary Journal 197, 280-285
74. RADOWICZ, S. N. & POWER, H. T. (2005) Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Veterinary Dermatology 16, 81-86
75. RADWANSKI, N. E., CERUNDOLO, R., SHOFER, F. S., HANLEY, M. J. & COURT, M. H. (2011) Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs. American Journal of Veterinary Research 72, 687-693
76. ROSENKRANTZ, W. S. (2004) Pemphigus: current therapy. Veterinary Dermatology 15, 90-98
77. ROSENKRANTZ, W. S. & ANIYA, J. S. (2007) Cyclosporine, ketoconazole and azathioprine combination therapy in three cases of refractory canine pemphigus foliaceus. Veterinary Dermatology 18, 192
78. ROSENKRANTZ, W. S., GRIFFIN, C. E. & BARR, R. J. (1989) Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotropic lymphoma. Journal of the American Animal Hospital Association 25, 377-384
79. RYBNICEK, J., AFFOLTER, V. K. & MOORE, P. F. (1998) Sebaceous adenitis: an immunohistological examination. In Advances in Veterinary Dermatology. Vol 3. Eds K. W. Kwochka, T. Willemse, C. Von Tscharner. Butterworth Heinemann. pp 539-540
80. SANTORO, D. & CAMPBELL, K. L. (2011) Use of ciclosporin in a dog with canine juvenile sterile granulomatous dermatitis and lymphadenitis. Veterinary Dermatology 22, 287-288
81. SIHRA, B. S., KON, O. M., DURHAM, S. R., WALKER, S., BARNES, N. C. & KAY, A. B. (1997) Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax 52, 447-452
82. STEFFAN, J. (2004) Cyclosporine interactions in veterinary medicine: an update. 5th World Congress of Veterinary Dermatology. Proceedings of the Atopica symposium. Vienna. pp 28-32
83. STEFFAN, J., ALEXANDER, D., BROVEDANI, F. & FISCH, R. D. (2003) Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Veterinary Dermatology 14, 11-22
84. STEFFAN, J., FAVROT, C. & MUELLER, R. (2006) A systematic review and metaanalysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 17, 3-16
85. STEFFAN, J., HORN, J., GRUET, P., STREHLAU, G., FONDATI, A., FERRER, L. & NOLI, C. (2004a) Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone. Veterinary Record 154, 681-684
86. STEFFAN, J., MAURER, M. & ROHLFS, A. (2003) Cyclosporin concentration in the skin following oral administration. Veterinary Dermatology 14, 248
87. STEFFAN, J., PARKS, C. & SEEWALD, W. (2005) Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 226, 1855-1863
88. STEFFAN, J., STREHLAU, G., MAURER, M. & ROHLFS, A. (2004b) Cyclosporin A pharmacokinetics and efficacy in the treatment of canine atopic dermatitis. Journal of Veterinary Pharmacology and Therapeutics 27, 231-238
89. TAKAORI, K., NIO, Y., INOUE, K., TUN, T., FUKUMOTO, M., HASHIDA, T., YASUHARA, M., HORI, R. & TOBE, T. (1992) A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. Biotherapy 4, 129-137
90. TAYLOR, A. L., WATSON, C. J. & BRADLEY, J. A. (2005) Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Critical Reviews in Oncology/Hematology 56, 23-46
91. THELEN, A., MUELLER, R. S., LINEK, M., PETERS, S., STECHMANN, K. & STEFFAN, J. (2006) Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis. Veterinary Record 159, 854-856
92. WHALEN, R. D., TATA, P. N., BURCKART, G. J. & VENKATARAMANAN, R. (1999) Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica 29, 3-9
93. WISSELINK, M. A. & WILLEMSE, T. (2009) The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study. Veterinary Journal 180, 55-59
94. WON, Y. H., SAUDER, D. N. & MCKENZIE, R. C. (1994) Cyclosporin A inhibits keratinocyte cytokine gene expression. British Journal of Dermatology 130, 312-319
95. WU, C. Y., BENET, L. Z., HEBERT, M. F., GUPTA, S. K., ROWLAND, M., GOMEZ, D. Y. & WACHER, V. J. (1995) Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clinical Pharmacology and Therapeutics 58, 492-497